CTBO (Cantabio Pharmaceuticals) Days Payable: 0.00 (As of Dec. 2018)


What is Cantabio Pharmaceuticals Days Payable?

Cantabio Pharmaceuticals CTBO Days Payable is 0.00 as of Dec. 2018.

Cantabio Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2018 was $0.64 Mil. Cantabio Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2018 was $0.00 Mil.

The historical rank and industry rank for Cantabio Pharmaceuticals's Days Payable or its related term are showing as below:

CTBO's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

Cantabio Pharmaceuticals's Days Payable stayed the same from Dec. 2017 (0.00) to Dec. 2018 (0.00). stayed the same

Cantabio Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Days Payable Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CTBO vs TNTY, ETNI, NTRR: Days Payable Comparison

For the Biotechnology subindustry, Cantabio Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantabio Pharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantabio Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Cantabio Pharmaceuticals's Days Payable falls into.


Cantabio Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cantabio Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2018 is calculated as

Days Payable (A: Mar. 2018 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2017 ) + Accounts Payable (A: Mar. 2018 )) / count ) / Cost of Goods Sold (A: Mar. 2018 )*Days in Period
=( (0.378 + 0.607) / 2 ) / 0*365
=0.4925 / 0*365
=N/A

Cantabio Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2018 is calculated as:

Days Payable (Q: Dec. 2018 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2018 ) + Accounts Payable (Q: Dec. 2018 )) / count ) / Cost of Goods Sold (Q: Dec. 2018 )*Days in Period
=( (0.641 + 0.642) / 2 ) / 0*365 / 4
=0.6415 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Cantabio Pharmaceuticals (CTBO) has a Days Payable of 0.00 as of Dec. 2018. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Days Payable too high?
Cantabio Pharmaceuticals' current Days Payable is 0.00.
How does Cantabio Pharmaceuticals' Days Payable compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Days Payable of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cantabio Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantabio Pharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Days Payable is 0.00 as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.